Bortezomib: Potential Key Role in the Treatment of Multiple Myeloma-Related Acquired Hemophilia A

Semin Thromb Hemost. 2017 Feb;43(1):109-112. doi: 10.1055/s-0036-1597648. Epub 2016 Dec 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Bortezomib / administration & dosage
  • Bortezomib / therapeutic use*
  • Hemophilia A / drug therapy*
  • Hemophilia A / etiology
  • Humans
  • Male
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*

Substances

  • Antineoplastic Agents
  • Bortezomib